What year was Fosamax taken off the market?
Merck’s annual sales of Fosamax regularly topped $3 billion before the company lost patent exclusivity in 2008. Fosamax is now available as a generic. Sales of Fosamax totaled $284 million last year, down from $3.05 billion in 2007.
Is Fosamax still being used?
March 17, 2004 – There is good news about the drugs used to treat and prevent osteoporosis-related bone loss. The longest-ever study of one of the most widely prescribed of these drugs suggests it continues to protect bones after a decade of use.
Why is Fosamax controversial?
Cases of osteonecrosis (literally “bone death”) of the jaw, a painful condition where jaw bones become exposed, were reported by people taking Fosamax. In 2013, Merck agreed to pay $27.7 million to settle 1,140 lawsuits from individuals who alleged that Fosamax caused them to develop this condition.
What is the safest drug to treat osteoporosis?
Bisphosphonates are usually the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel), a weekly or monthly pill.
What was the settlement for Fosamax lawsuit?
Fosamax Lawsuits Plaintiffs who filed lawsuits against Merck for its osteoporosis drug Fosamax claim that the drug caused osteonecrosis of the jaw (ONJ) and femur fractures. Allegations against the drug company include failure to warn and manufacturing a defective drug. Merck settled about 1,200 ONJ cases for $27.7 million.
Does Fosamax cause thigh fractures?
Following a trip to the U.S. Supreme Court, Merck & Co has convinced a judge to toss more than 500 lawsuits alleging it failed to warn Fosamax users about the risks of developing thigh bone fractures associated with the osteoporosis drug.
Did Fosamax cause damage to my jaw?
The plaintiff had claimed that the pharmaceutical giant’s Fosamax osteoporosis treatment medication has caused significant damage to her jaw. The jury award is considered a major victory by many plaintiffs who have filed more than 900 lawsuits against the Drug Maker.
Is Merck liable for Fosamax’s risks?
In general, these lawsuits claim Merck is liable for “concealment of risks associated with Fosamax,” “gross exaggeration of the purported fracture reduction benefits conferred by the drugs,” and “overpromotion of the drugs for non-approved, or ‘off-label,’ indications.”